CIK 0001015820 · Biological Products, (No Diagnostic Substances) (SIC 2836) · NYSE · incorporated in P7 · fiscal year ends 12/31
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-09-09 | 6-K | 6-K | 2026-09-30 |
| 2026-08-07 | 6-K | 6-K | 2026-06-30 |
| 2026-08-07 | 6-K | 6-K | 2026-06-30 |
| 2026-08-07 | 6-K | 6-K | 2026-06-30 |
| 2026-06-05 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-06-01 | SD | SD | |
| 2026-05-08 | 6-K | 6-K | 2026-03-31 |
| 2026-05-08 | 6-K | 6-K | 2026-03-31 |
| 2026-05-01 | 6-K | 6-K | 2026-03-31 |
| 2026-03-20 | IRANNOTICE | IRANNOTICE | |
| 2026-03-20 | 20-F | 20-F | 2025-12-31 |
| 2026-02-10 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-02-06 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-02-06 | 6-K | 6-K | 2025-12-31 |
| 2026-01-09 | 25-NSE/A | 25-NSE/A | |
| 2026-01-08 | 25-NSE | 25-NSE | |
| 2025-12-22 | 6-K | 6-K | 2025-12-31 |
| 2025-11-12 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2025-11-06 | 6-K | 6-K | 2025-09-30 |
| 2025-11-06 | 6-K | 6-K | 2025-09-30 |
| 2025-09-02 | 6-K | 6-K | 2025-08-31 |
| 2025-08-21 | 6-K | 6-K | 2025-06-30 |
| 2025-08-15 | 144 | 144 | |
| 2025-08-15 | 144 | 144 | |
| 2025-08-14 | 144 | 144 |
Forms on file (last 1,000): 6-K 242, SC 13G/A 51, SC TO-T/A 27, 20-F 25, UPLOAD 20, 425 16, CORRESP 15, SD 13. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=QGEN (0.002 USD), /gw/filings/filings?ticker=QGEN&form=8-K, /gw/filings/facts?ticker=QGEN&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange